Blonder Tongue Laboratories, Inc., a technology-development and manufacturing company, provides television (TV) signal encoding, transcoding, digital transport, and broadband product solutions in the United States. More Details
Adequate balance sheet with weak fundamentals.
Share Price & News
How has Blonder Tongue Laboratories's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: BDR is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 21% a week.
Volatility Over Time: BDR's weekly volatility (21%) has been stable over the past year, but is still higher than 75% of US stocks.
7 Day Return
1 Year Return
Return vs Industry: BDR exceeded the US Communications industry which returned -1.8% over the past year.
Return vs Market: BDR exceeded the US Market which returned 23.7% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Blonder Tongue Laboratories's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 month ago | Simply Wall StHave Blonder Tongue Laboratories, Inc. (NYSEMKT:BDR) Insiders Been Selling Their Stock?
3 months ago | Simply Wall StIs Blonder Tongue Laboratories (NYSEMKT:BDR) A Risky Investment?
7 months ago | Simply Wall StThe Blonder Tongue Laboratories (NYSEMKT:BDR) Share Price Is Down 46% So Some Shareholders Are Getting Worried
Is Blonder Tongue Laboratories undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate BDR's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate BDR's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: BDR is unprofitable, so we can't compare its PE Ratio to the US Communications industry average.
PE vs Market: BDR is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate BDR's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: BDR is overvalued based on its PB Ratio (5.6x) compared to the US Communications industry average (2.6x).
How is Blonder Tongue Laboratories forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Tech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Blonder Tongue Laboratories has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine Blonder Tongue Laboratories's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
- Blonder Tongue Laboratories competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Tech industry.
How has Blonder Tongue Laboratories performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: BDR is currently unprofitable.
Growing Profit Margin: BDR is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: BDR is unprofitable, but has reduced losses over the past 5 years at a rate of 5.1% per year.
Accelerating Growth: Unable to compare BDR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BDR is unprofitable, making it difficult to compare its past year earnings growth to the Communications industry (-0.1%).
Return on Equity
High ROE: BDR has a negative Return on Equity (-340.59%), as it is currently unprofitable.
How is Blonder Tongue Laboratories's financial position?
Financial Position Analysis
Short Term Liabilities: BDR's short term assets ($8.2M) exceed its short term liabilities ($6.2M).
Long Term Liabilities: BDR's short term assets ($8.2M) exceed its long term liabilities ($4.7M).
Debt to Equity History and Analysis
Debt Level: BDR's debt to equity ratio (108.2%) is considered high.
Reducing Debt: BDR's debt to equity ratio has increased from 67.6% to 108.2% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BDR has sufficient cash runway for 0 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: BDR is forecast to have sufficient cash runway for 0 months based on free cash flow estimates, but has since raised additional capital.
What is Blonder Tongue Laboratories's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate BDR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate BDR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if BDR's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if BDR's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of BDR's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Ted Grauch (54 yo)
Mr. Edward Rowland Grauch, also known as Ted, has been the Chief Executive Officer at Blonder Tongue Laboratories, Inc. since January 1, 2020. Mr. Grauch has been the President of Blonder Tongue Laboratori...
CEO Compensation Analysis
Compensation vs Market: Ted's total compensation ($USD323.98K) is below average for companies of similar size in the US market ($USD529.89K).
Compensation vs Earnings: Ted's compensation has been consistent with company performance over the past year.
|President & CEO||1yr||US$323.98k||2.68% |
|Senior VP||19.67yrs||US$278.84k||0.17% |
|Senior Vice President of Operations||1yr||US$249.50k||0.76% |
|Senior VP of Engineering & CTO||2.5yrs||US$285.78k||0.30% |
Experienced Management: BDR's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
|Independent Director||12.92yrs||US$59.54k||2.1% |
|Independent Director||23.08yrs||US$50.67k||2.46% |
|Independent Director||27.33yrs||US$55.54k||1.99% |
|Independent Director||5.92yrs||US$50.54k||3.75% |
|Independent Director||3yrs||US$59.64k||0.75% |
|Independent Chairman||5.67yrs||US$90.14k||5.6% |
|Independent Director||9.33yrs||US$63.28k||2.51% |
|Independent Director||1yr||no data||no data|
|Independent Director||0.58yr||no data||0.062% |
|Independent Director||0.42yr||no data||0.14% |
Experienced Board: BDR's board of directors are considered experienced (5.8 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: BDR insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 20%.
Blonder Tongue Laboratories, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Blonder Tongue Laboratories, Inc.
- Ticker: BDR
- Exchange: AMEX
- Founded: 1950
- Industry: Communications Equipment
- Sector: Tech
- Market Cap: US$17.221m
- Shares outstanding: 11.56m
- Website: https://www.blondertongue.com
Number of Employees
- Blonder Tongue Laboratories, Inc.
- One Jake Brown Road
- Old Bridge
- New Jersey
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|BDR||AMEX (NYSE MKT LLC)||Yes||Common Stock||US||USD||Dec 1995|
Blonder Tongue Laboratories, Inc., a technology-development and manufacturing company, provides television (TV) signal encoding, transcoding, digital transport, and broadband product solutions in the Unite...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/01/23 23:40|
|End of Day Share Price||2021/01/22 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.